Inozyme Pharma
Inozyme Pharma is an enzyme Replacement Therapy founded in 2016.
3
Funding Rounds
$183.0m
Money raised
| Name | Phone | Social networks | |
|---|---|---|---|
| Ed Ma***** | - | - | |
| Ma**** Ed***** (e************ | - | - | - |
| Sa*** Bh**** | - | - | - |
| Do** Tr*** | - | - | - |
| LY*** SU****** | - | - | |
| Ax** Bo*** | - | - | |
| Ro* Ho***** | - | - | - |
| Re****** M. Di** | - | - | - |
Funding
Funding series
Funding Series Analysis
The company Inozyme Pharma has raised a total of $116m in funding over 3 rounds.
Key Insights:
- Inozyme Pharma Series A round, April 2019: $67m
- Inozyme Pharma Series A round, November 2017: $49m
- Inozyme Pharma Inc funding round, April 2019: $67m
Inozyme Pharma Series A round, April 2019
$67m
Inozyme Pharma Series A round, November 2017
$49m
Inozyme Pharma Inc funding round, April 2019
$67m
Industries
Inozyme Pharma is active in the following industries:
- Biopharmaceutical
- Biomedical engineering
- Chemistry
- Drug metabolism
- Enzyme kinetics
- Pharmacokinetics
- Technology
- Biology
- Biotechnology
- Engineering
- Rare disease